| CAS No. | 154039-60-8 |
|---|---|
| MDL No. | MFCD00866242 |
| MF | C15H29N3O5 |
| MW | 331.41 |
| InChI Key | OCSMOTCMPXTDND-OUAUKWLOSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $46 | In Stock | |
| 5 mg | 98% | $55 | In Stock | |
| 25 mg | 98% | $177 | In Stock | |
| 50 mg | 98% | $262 | In Stock | |
| 100 mg | 98% | $418 | In Stock | |
| 250 mg | 98% | $625 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Marimastat is a secondary carboxamide formed by the formal condensation of the carboxy group of (2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the alpha-amino group of N,3-dimethyl-L-valinamide. It functions as an antineoplastic agent and matrix metalloproteinase inhibitor, and is classified as a secondary carboxamide and hydroxamic acid.
| CAS No. | 154039-60-8 |
|---|---|
| Product Name | Marimastat |